webBlog Homepage | Iforg Homepage

advertisement

Podcast [Feb.07]: Project Bedfordshire-Medicines Use Review (Part 3)

February 17th, 2008

In this final podcast installment, Kate interviews Cyril Siou, Perveen Bhardwaj and Richard Andoh, all members of the project implementation team about the different components of the Bedfordshire project…finally Kate discusses an item from our blog entitled ‘Making anticoagulation therapy safer’ and appeared on our blog in May 2007

The project team
Top Left then Clockwise: Kate and Cyril; Kate and Perveen; All the team; Kate and Richard

Go to www.iforg.com/podcast.asp for details

Project: Devon [Status: Delayed]

February 10th, 2008

The launch of project Devon has been delayed by 2 months due to unforeseen circumstances. We are sorry about the delay.

Thanks
Webmaster
Iforg Limited

Podcast [Jan.07]: Project Bedfordshire-Medicines Use Review (Part 2)

January 21st, 2008

This is the second of three podcasts introducing the Bedfordshire project. In this podcast, Kate interviews Jaggy Khela, a member of the project implementation team, who gives an overview of the project….and finally Kate discusses an item on our webBlog. The article was entitled: Why would you not want to know? and was written by Kazeem in December 2008.

Kate interviews Jaggy
Kate interviews Jaggy

go to: http://www.iforg.com/podcast.asp

Why would you not want to know?

December 20th, 2007

by Kazeem Olalekan MRPharmS

Do you remember the Aesop’s Fable about the Fox and the Grapes?

A FAMISHED FOX saw some clusters of ripe black grapes hanging from a trellised vine. She resorted to all her tricks to get at them, but wearied herself in vain, for she could not reach them. At last she turned away, hiding her disappointment and saying: “The Grapes are sour, and not ripe as I thought.” (1)

The above is a fable about persistence. Might the outcome have been different if the Fox has been more persistent? One would never know. See how easy it was for the Fox to despise what seemed unattainable.

Read the rest of this entry »

County {Devon}: Resources

December 2nd, 2007

Wikipedia: Devon

Districts:

1. Exeter
2. East Devon
3. Mid Devon
4. North Devon
5. Torridge
6. West Devon
7. South Hams
8. Teignbridge
9. Plymouth (Unitary)
10. Torbay (Unitary)

devon map
image courtesy of Keith Edkins

Devon County Council

Devon is the third largest of the English counties. The county town is the cathedral city of Exeter. Discover Devon (URL: http://www.discoverdevon.com) is the website to visit for information on where to stay, things to do and areas to visit.

As part of our project strategy, we will find a day to pay a visit to Devon and identify which charity, the devon project will support. We will make sure we pay the Dartmoor National Park a visit.
The moor, as is commonly called, has a number of qualities which include remarkable landscape, heather-covered moorland and deep wooded gorges, beautiful lake-like reservoirs and tumbling rocky rivers, thriving market towns and villages, patchwork farmland and craggy granite tors. Dartmoor National Park is the largest, and wildest, area of open country in southern England.

1 Star2 Stars3 Stars4 Stars5 Stars (1 votes, average: 3 out of 5)
Loading ... Loading …

Podcast [Dec.07]: Project Bedfordshire-Medicines Use Review (Part 1)

December 1st, 2007

This is the first of three podcasts focusing on our Bedfordshire project. The project is about the Medicines Use Review (MUR) component of the new Pharmacy NHS contract in England and Wales.

In this podcast, Kate describes the background to the project. As we move closer to the launch of the BETA version of the project, we will use a series of 3 podcasts to describe what has been happening with the project.

…and finally, Kate will discuss an item on our webBlog. The article was entitled: Why withdraw Exubera? and was written by Kazeem in October 2007.

project logo

go to: http://www.iforg.com/podcast.asp

REFERENCES:

  • What the new contract has in store: by Clare Bellingham: The Pharmaceutical Journal (Vol 273) 18 September 2004; page 385: Link (.pdf)
  • How to offer a medicines use review: by Clare Bellingham: The Pharmaceutical Journal (Vol 273) 23 October 2004; page 602: Link (.pdf)
  • Community pharmacy: essential and advanced services: The NHS Confederation; November 2004; Link (.pdf)
  • 1 Star2 Stars3 Stars4 Stars5 Stars (1 votes, average: 4 out of 5)
    Loading ... Loading …

    Career in Pharmacy - how rude!

    December 1st, 2007

    funny? you bet..

    I hope we do more than this though!

    courtesy of nousernamesarefree channel

    - Kazeem

    1 Star2 Stars3 Stars4 Stars5 Stars (1 votes, average: 3 out of 5)
    Loading ... Loading …

    Podcast [Nov.07]: Iforg Introduction

    November 4th, 2007

    In this our inaugural podcast, Kate provides a brief summary of what we are about at Iforg Limited. She describes where to find items on our websites, our project strategies and how you can contribute to our contents.

    We also describe here the structure of our monthly podcasts so that you can find items more readily.

    ..and finally we discuss an item on our blog: The power of observation – the pill counter example, published in March 2007.

    Kate Penhaigon - Project Facilitator
    Kate Penhaligon-Project Facilitator and Podcaster General!

    http://www.iforg.com/podcast.asp

    1 Star2 Stars3 Stars4 Stars5 Stars (1 votes, average: 3 out of 5)
    Loading ... Loading …

    Project: Devon [Status: Active]

    October 26th, 2007

    The status of project Devon has changed to Active: This means that we are now currently working actively on this project.

    As part of this process, we have decided to take down the site [www.healthcare-events.info] until we launch the new site.

    We apologize to our users for any inconveniences. This is a necessary upgrade to add more functionality to this site. We aim to complete this project in 3 months.

    Webmaster
    Iforg Limited

    Why withdraw Exubera?

    October 22nd, 2007

    by Kazeem Olalekan MRPharmS

    Pfizer has decided to withdraw its novel inhaled insulin, Exubera..not because of safety problems…not beacuse of negative response from patients but because ‘too few patients are taking EXUBERA’ (1)

    How could this be? Diabetic patients have been crying for a less painful way of administering insulin for years..Here is a product that requires no injection but prescibers are not using it.

    Read the rest of this entry »

     


    Close
    E-mail It